Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age5+
SponsorPeter Merkel

About this trial

Multi-center observational study to evaluate the histopathology and transcriptome of cutaneous lesions in patients with several different types of vasculitis.

Eligibility criteria

Qualifiers

Have a cutaneous lesion (purpuric macules, palpable purpura, retiform purpura, nodules, ulcers, or urticarial) believed to be related to active vasculitis

Cryoglobulinemic vasculitis (CV)

Drug-induced vasculitis

Eosinophilic granulomatosis with polyangiitis (EGPA)

Disqualifiers

You are less than five years old

Considered not to be a candidate for a biopsy or have a higher risk of developing an infection, bleeding, etc., from the biopsy, or a doctor believes that the risks for you participating in this study do not outweigh the potential benefit of learning information from your biopsy

You have a neutrophil count (type of white blood cell) less than 1500/mm3, platelet count less than 50,000/mm3, or a hemoglobin less than 7 g/dL

You have an uncontrolled disease that could prevent you from completing the study procedures

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Peter Merkel

Lead sponsor

University of Pennsylvania

Sponsor institution

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Collaborator

National Center for Advancing Translational Sciences (NCATS)

Collaborator

Office of Rare Diseases Research (ORDR)

Collaborator